Why Women Experience GLP-1 Weight Loss Stalls Differently Than Men

By GLPeak Team · 2026-03-02

Frustrated by slow progress? Discover how hormones and biology impact GLP-1 weight loss for women and why your "stall" might actually be a long-term advantage.

Starting a weight loss journey with a male partner or friend can lead to a common frustration: his progress seems rapid and linear, while yours is subject to stalls and shifts. Despite taking the same medication and following similar habits, the biological reality for women is more complex.

Current research indicates that weight loss plateaus in women are often driven by hormonal fluctuations rather than behavioral choices. Understanding these biological variables can help you manage expectations and stay on track.

The Biological Variance in Weight Loss

Recent meta-analyses of GLP-1 clinical trials show that while men often lose weight more quickly in the initial months, women generally achieve a higher total percentage of weight loss over a longer duration. This variance is influenced by two primary factors:

• Body Composition: Men typically have more lean muscle mass, which contributes to a slightly higher Basal Metabolic Rate (BMR). They also carry more visceral fat, which is metabolically active and mobilizes faster than the subcutaneous fat typically stored by women for reproductive health.

• Hormonal Synergy: Emerging research suggests that estrogen may actually enhance the effects of GLP-1 medications. Estrogen and GLP-1 receptors are both found in brain regions that regulate appetite and reward, potentially making the medication more effective for women when estrogen levels are stable.

The "Hungry Week" and the Luteal Phase

A common experience for women on GLP-1s is the feeling that the medication "stops working" for one week every month. This usually occurs during the luteal phase (the two weeks between ovulation and your period).

During this phase, progesterone levels rise significantly. Progesterone is naturally thermogenic—it increases your body temperature and metabolic rate by about 2% to 10%—but it also stimulates appetite and can increase mild insulin resistance. This biological signal to eat can sometimes override the satiety signals provided by GLP-1 medications, leading to increased cravings.

Fluid Retention and the "False" Plateau

Hormonal shifts also trigger fluid retention. Research shows women can retain 3 to 5 pounds of water weight during the premenstrual phase. On the scale, this appears as a stall or a gain, even if fat loss is still occurring.

Strategies for Long-Term Success

1. Shift Your Comparisons: Rather than tracking week-over-week, compare your weight on the same day of each menstrual cycle (e.g., the first day of your period vs. the first day of your last period). This accounts for cyclical water retention.

2. Maintain Protein Intake: Since progesterone increases metabolic demand slightly, focus on lean protein during the luteal phase. This supports satiety and helps protect lean muscle mass.

3. Prioritize Hydration: GLP-1s can reduce thirst signals. Proper hydration is essential to help the body process sodium and reduce bloating.

4. Incorporate Resistance Training: Protecting muscle mass is vital for maintaining a healthy metabolic rate. Strength training at least twice a week ensures that the weight you lose is primarily fat.

5. Look Beyond the Scale: Use measurements and photos. Changes in body composition (inches lost) often continue even when the scale is temporarily masked by fluid shifts.

Consistency remains the most important factor. Biological software is complex, and a stall on the scale is often just a sign of your body’s natural hormonal regulation in action.

Primary Research References

1. Yang, et al. (2025). Treating obesity with GLP-1 RAs: does sex matter? Journal of Diabetes. This meta-analysis of 47 trials confirms that while men lose weight faster initially, women often experience a greater total percentage of weight loss over time.

2. Benton, M. J., et al. (2020). Metabolic Rate and Fuel Utilization Across the Menstrual Cycle. International Journal of Environmental Research and Public Health. This study details the 2% to 10% rise in metabolic rate during the luteal phase due to progesterone.

3. Olio Labs (2025/2026). Sex differences in GLP-1 signaling. Research highlighting how estrogen interacts with GLP-1 receptors in the brain to influence satiety and nausea.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with your healthcare provider regarding changes to your medication or symptoms.